Whitehawk Therapeutics, Inc. — Director's Dealing 2018

Nov 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2018-11-09

Reporting Person: HOFFMAN STEPHEN J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	Common Stock	P	1967	$1.95	Acquired	1967	Direct
2018-11-12	Common Stock	P	30000	$2.01	Acquired	31967	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.95 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.